COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical par...

FDA Device Recall #Z-0401-2021 — Class II — September 30, 2020

Recall Summary

Recall Number Z-0401-2021
Classification Class II — Moderate risk
Date Initiated September 30, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Merz North America, Inc.
Location Franksville, WI
Product Type Devices
Quantity 2051 units

Product Description

COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.

Reason for Recall

The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.

Distribution Pattern

US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV

Lot / Code Information

Model M0068903000, Lots: 100127846, 100127847, 100128709, 100128710, 100129357, 100129614, and 100129615

Other Recalls from Merz North America, Inc.

Recall # Classification Product Date
Z-2607-2016 Class II Radiesse (+) Lidocaine, Injectable Implant 1.5c... May 20, 2016
Z-0368-2016 Class II PROLARYN PLUS Injectable Implant 1.0 cc Plus Ca... Oct 26, 2015
Z-0366-2016 Class II Radiesse (+) Lidocaine Injectable Implant 1.5cc... Oct 26, 2015
Z-0367-2016 Class II PROLARYN Injectable Implant 1.0 cc Gel, Model N... Oct 26, 2015

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.